With over three decades of extensive industry experience, Ramesh Juneja brings a strong track record of building and scaling large businesses
US formulations grew 11% to Rs. 564 crore as Alembic enters US branded pharmaceuticals market with launch of Pivya
Enthral.ai’s platform integrates AI-driven capabilities with compliance-first architecture, enabling automated training workflows
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Stalevo Tablets
The inspection was carried out between May 26, 2025 and May 31, 2025
Alembic receives EIR from USFDA for facility at Panelav
The India Branded Business delivered a 5% YoY growth, reaching Rs. 599 crore in revenue for the quarter
Carbamazepine Extended-Release Tablets are indicated for use as an anticonvulsant drug
The acquisition of Pivya is an important step in Alembic’s ability to provide branded pharmaceutical product to the US Healthcare market
Amlodipine and Atorvastatin tablets are indicated in patients for whom treatment with both amlodipine and atorvastatin
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
